Molecular biophysics at the University of Pennsylvania has a long and rich history. Eldridge Reeves Johnson, the former president of the Victor Talking Machine Company (RCA), gave the University a generous endowment in 1927 to establish first organization in this country dedicated to medical physics. The Johnson Foundation (JF) was established for the "study and development of physical methods in the investigation of disease and in its cure." Under the initial leadership of Detlev Bronk and then Britton Chance, the JF established Penn as a world-center for physical biochemistry and biophysics. Investigators in the JF expanded methods for studying action potentials, developed innovative techniques of biological oxygen detection, introduced a range of instrumentation for study of fast reactions, explored applications of new technologies such as ultrasound, electron microscopy, EPR, NMR and MRI. The Johnson Foundation, now under the direction of P. Leslie Dutton, has continued to evolve and expand into structural and computational biology, high-resolution NMR spectroscopy, protein dynamics &folding and single molecule approaches to a variety of fundamental questions in human biology. The JF is centered in a dynamic department of Biochemistry &Biophysics that is focused on quantitative biochemistry and biophysics. It is in this strong framework that the training program in Structural Biology and Molecular Biophysics promotes the application of structural biology and molecular biophysics to clinically relevant research. It is the flagship predoctoral training program for quantitative biology in the medical school and arguably for the entire University. The fundamental goal of our training mission is to produce biophysicists who can effectively integrate and apply the physical methodologies to medically relevant research problems. Our program explicitly integrates human biology and pathology into the graduate curriculum. The SBMB training program is designed to produce well-rounded scientists with expertise in structural biology and biophysics as well as have a solid foundation in biomedical sciences and disease. Historically, our trainees come to the program with diverse educational backgrounds that range from physics, chemistry, biology, engineering and biochemistry, even pure math. To accommodate this diversity, the training program provides extensive flexibility in the construction of personalized curricula. The research resources offered by the University of Pennsylvania are matched by few universities in the world. Importantly, the fact that all schools of the University are located on one contiguous campus provides a significant advantage for collaborative interactions across disciplines, something that is important to structural biology and molecular biophysics. The faculty provided by this training program are creative, well-funded investigators with a demonstrable track-record of teaching and mentorship. With the emergence of translational medicine as a priority it seems a priority to maintain a broadly educated capability in structural biology and molecular biophysics and, with this in mind, the program at the University of Pennsylvania is designed to produce well- trained and synoptically thinking biophysical scientists.
Basic research in structural biology and molecular biophysics provides the foundation upon which modern medicine rests. This training program in structural biology and molecular biophysics seeks to provide a creative and comprehensive environment for training the leaders of the future. It will do so by sustaining a rigorous program in these ares while providing a strong biomedical context. The emphasis on quantitative aspects of biology is both timely and necessary to maintain the strength of the United States'leadership in biomedical research.
|Culik, Robert M; Abaskharon, Rachel M; Pazos, Ileana M et al. (2014) Experimental validation of the role of trifluoroethanol as a nanocrowder. J Phys Chem B 118:11455-61|
|Bessman, Nicholas J; Bagchi, Atrish; Ferguson, Kathryn M et al. (2014) Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. Cell Rep 9:1306-17|
|Bresler, Scott C; Weiser, Daniel A; Huwe, Peter J et al. (2014) ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell 26:682-94|
|Slochower, David R; Wang, Yu-Hsiu; Tourdot, Richard W et al. (2014) Counterion-mediated pattern formation in membranes containing anionic lipids. Adv Colloid Interface Sci 208:177-88|
|Moorman, Veronica R; Valentine, Kathleen G; Bédard, Sabrina et al. (2014) Dynamic and thermodynamic response of the Ras protein Cdc42Hs upon association with the effector domain of PAK3. J Mol Biol 426:3520-38|
|Wang, Yu-Hsiu; Slochower, David R; Janmey, Paul A (2014) Counterion-mediated cluster formation by polyphosphoinositides. Chem Phys Lipids 182:38-51|
|Marques, Bryan S; Nucci, Nathaniel V; Dodevski, Igor et al. (2014) Measurement and control of pH in the aqueous interior of reverse micelles. J Phys Chem B 118:2020-31|
|Bessman, Nicholas J; Freed, Daniel M; Lemmon, Mark A (2014) Putting together structures of epidermal growth factor receptors. Curr Opin Struct Biol 29:95-101|
|Malecka, Kimberly A; Fera, Daniela; Schultz, David C et al. (2014) Identification and characterization of small molecule human papillomavirus E6 inhibitors. ACS Chem Biol 9:1603-12|
|Dersh, Devin; Jones, Stephanie M; Eletto, Davide et al. (2014) OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation. Mol Biol Cell 25:2220-34|
Showing the most recent 10 out of 60 publications